Adrenocortical Carcinoma

Search Trials
Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
Status:
Completed
Last Changed:
Apr 25, 2017
First Changed:
Jan 23, 2012
Disease(s):
Adrenocortical Carcinoma
Intervention(s):
Dovitinib
Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma
Status:
Unknown status
Last Changed:
Oct 30, 2018
First Changed:
Oct 30, 2018
Disease(s):
Adrenocortical Carcinoma
Intervention(s):
Cisplatin plus EtoposideObservation or Mitotane
Cabozantinib in Unresectable/Metastatic Adrenocortical Carcinoma
Status:
Recruiting
Last Changed:
Jan 9, 2019
First Changed:
Dec 12, 2017
Disease(s):
Adrenocortical Carcinoma
Intervention(s):
Cabozantinib
Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
Status:
Active, not recruiting
Last Changed:
Mar 14, 2022
First Changed:
Feb 3, 2016
Disease(s):
Adrenocortical Carcinoma
Intervention(s):
Pembrolizumab
Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines
Status:
Unknown status
Last Changed:
Apr 11, 2018
First Changed:
Aug 22, 2017
Disease(s):
Adrenocortical Carcinoma
Intervention(s):
Cabazitaxel

Connect. Empower. Inspire.